Suppr超能文献

神经肽激素催产素与进食障碍

The Neuropeptide Hormone Oxytocin in Eating Disorders.

机构信息

Neuroendocrine Unit, Massachusetts General Hospital and Department of Medicine, Harvard Medical School, 55 Fruit Street BUL457, Boston, MA, 02114, USA.

Eating Disorders Clinical and Research Program, Massachusetts General Hospital and Department of Psychiatry, Harvard Medical School, Boston, MA, USA.

出版信息

Curr Psychiatry Rep. 2018 Sep 4;20(10):91. doi: 10.1007/s11920-018-0957-0.

Abstract

PURPOSE OF REVIEW

The neurohormone oxytocin (OXT) impacts food intake as well as cognitive, emotional, and social functioning-all of which are central to eating disorder (ED) pathology across the weight spectrum. Here, we review findings on endogenous OXT levels and their relationship to ED pathology, the impact of exogenous OXT on mechanisms that drive ED presentation and chronicity, and the potential role of genetic predispositions in the OXT-ED link.

RECENT FINDINGS

Current findings suggest a role of the OXT system in the pathophysiology of anorexia nervosa. In individuals with bulimia nervosa, endogenous OXT levels were comparable to those of healthy controls, and exogenous OXT reduced food intake. Studies in other ED are lacking. However, genetic studies suggest a broad role of the OXT system in influencing ED pathology. Highlighting findings on why OXT represents a potential biomarker of and treatment target for ED, we advocate for a systematic research approach spanning the entire ED spectrum.

摘要

目的综述

神经激素催产素(OXT)影响食物摄入以及认知、情绪和社交功能,所有这些都是贯穿整个体重谱的饮食失调(ED)病理的核心。在这里,我们回顾了内源性 OXT 水平及其与 ED 病理的关系、外源性 OXT 对驱动 ED 表现和持续性的机制的影响,以及遗传易感性在 OXT-ED 联系中的潜在作用。

最近的发现

目前的研究结果表明,OXT 系统在神经性厌食症的病理生理学中发挥作用。在神经性贪食症患者中,内源性 OXT 水平与健康对照组相当,外源性 OXT 可减少食物摄入。其他 ED 的研究则缺乏。然而,遗传研究表明 OXT 系统在影响 ED 病理方面具有广泛的作用。鉴于 OXT 是 ED 的潜在生物标志物和治疗靶点的研究结果,我们主张采用系统的研究方法来涵盖整个 ED 谱。

相似文献

1
The Neuropeptide Hormone Oxytocin in Eating Disorders.
Curr Psychiatry Rep. 2018 Sep 4;20(10):91. doi: 10.1007/s11920-018-0957-0.
2
Oxytocin and Eating Disorders: A Narrative Review on Emerging Findings and Perspectives.
Curr Neuropharmacol. 2018;16(8):1111-1121. doi: 10.2174/1570159X15666171128143158.
3
A systematic review of the effects of neuromodulation on eating and body weight: evidence from human and animal studies.
Eur Eat Disord Rev. 2013 Nov;21(6):436-55. doi: 10.1002/erv.2256. Epub 2013 Sep 20.
4
Neuroendocrinology and brain imaging of reward in eating disorders: A possible key to the treatment of anorexia nervosa and bulimia nervosa.
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt B):132-142. doi: 10.1016/j.pnpbp.2017.02.020. Epub 2017 Mar 1.
5
The use of intranasal oxytocin in the treatment of eating disorders.
Neuropeptides. 2023 Dec;102:102387. doi: 10.1016/j.npep.2023.102387. Epub 2023 Oct 12.
6
7
Oxytocin and Its Relationship to Body Composition, Bone Mineral Density, and Hip Geometry Across the Weight Spectrum.
J Clin Endocrinol Metab. 2017 Aug 1;102(8):2814-2824. doi: 10.1210/jc.2016-3963.
8
Molecular bases of anorexia nervosa, bulimia nervosa and binge eating disorder: shedding light on the darkness.
J Neurogenet. 2017 Dec;31(4):266-287. doi: 10.1080/01677063.2017.1353092. Epub 2017 Aug 1.
9
Peripheral oxytocin concentrations in psychiatric disorders - A systematic review and methanalysis: Further evidence.
Prog Neuropsychopharmacol Biol Psychiatry. 2022 Jul 13;117:110561. doi: 10.1016/j.pnpbp.2022.110561. Epub 2022 Apr 21.

引用本文的文献

3
Peripheral Biomarkers of Anorexia Nervosa: A Meta-Analysis.
Nutrients. 2024 Jun 30;16(13):2095. doi: 10.3390/nu16132095.
4
Understanding oxytocin in human physiology and pathophysiology: A path towards therapeutics.
Compr Psychoneuroendocrinol. 2024 May 28;19:100242. doi: 10.1016/j.cpnec.2024.100242. eCollection 2024 Aug.
5
Oxytocin in the Treatment of Psychiatric Disorders.
Medeni Med J. 2023 Sep 28;38(3):218-231. doi: 10.4274/MMJ.galenos.2023.13707.
6
Oxytocin response to food intake in avoidant/restrictive food intake disorder.
Eur J Endocrinol. 2023 Aug 2;189(2):149-155. doi: 10.1093/ejendo/lvad087.
8
OXTR DNA methylation differentiates men on the obesity spectrum with and without binge eating disorder.
Clin Epigenetics. 2022 Aug 30;14(1):108. doi: 10.1186/s13148-022-01318-3.
10
Oxytocin: A Potential Therapeutic for Obesity.
J Obes Metab Syndr. 2021 Jun 30;30(2):115-123. doi: 10.7570/jomes20098.

本文引用的文献

2
Effects of intranasal oxytocin on the attentional bias to emotional stimuli in patients with bulimia nervosa.
Psychoneuroendocrinology. 2018 May;91:75-78. doi: 10.1016/j.psyneuen.2018.02.029. Epub 2018 Mar 3.
4
Intranasal oxytocin in the treatment of anorexia nervosa: Randomized controlled trial during re-feeding.
Psychoneuroendocrinology. 2018 Jan;87:83-92. doi: 10.1016/j.psyneuen.2017.10.014. Epub 2017 Oct 14.
5
Low oxytocin levels are related to alexithymia in anorexia nervosa.
Int J Eat Disord. 2017 Nov;50(11):1332-1338. doi: 10.1002/eat.22784. Epub 2017 Oct 16.
6
Oxytocin receptors (OXTR) and early parental care: An interaction that modulates psychiatric disorders.
Res Dev Disabil. 2018 Nov;82:27-38. doi: 10.1016/j.ridd.2017.10.007. Epub 2017 Oct 21.
7
The effects of oxytocin on eating behaviour and metabolism in humans.
Nat Rev Endocrinol. 2017 Dec;13(12):700-709. doi: 10.1038/nrendo.2017.115. Epub 2017 Sep 29.
9
Alexithymia in eating disorders: Systematic review and meta-analyses of studies using the Toronto Alexithymia Scale.
J Psychosom Res. 2017 Aug;99:66-81. doi: 10.1016/j.jpsychores.2017.06.007. Epub 2017 Jun 11.
10
Oxytocin and Its Relationship to Body Composition, Bone Mineral Density, and Hip Geometry Across the Weight Spectrum.
J Clin Endocrinol Metab. 2017 Aug 1;102(8):2814-2824. doi: 10.1210/jc.2016-3963.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验